Viral hepatitis B and C endanger 325 million people

The World Health Organization (WHO) and its partners are calling on countries to urgently scale up hepatitis and treatment services to eliminate viral hepatitis as a threat for public health by 2030. Apel is on the eve of World Hepatitis Day. "Test, treatment, hepatitis," said WHO Friday

– We have a clear vision of the elimination of the disease and we have the means to do it. However, we must accelerate progress in order to reach our goal of eliminating hepatitis by 2030 – Dr. Tedros Adhan Ghebreyesus, Director-General of WHO

Viral hepatitis B and C endanger 325 million people worldwide. If left untreated, these infections lead to liver cancer and cirrhosis, which together caused more than 1.3 million deaths worldwide in 2015.

Worldwide, less than 20% of people have access to screening and treatment services To mark World Hepatitis Day, WHO has held several events with the Government of Mongolia, a country heavily burdened by the burden of hepatitis , but also a champion in the global fight against infection

More than 10% of the three million people of Mongolia live with chronic hepatitis. The country launched its national healthy health program in 2017 with ambitious targets for 2020.

Mongolia intends to allow hepatitis B and C testing for 1.8 million of people over 15 years old.

The fight against hepatitis is motivated by political commitment and ambitious planning in the field of public health. This country is the first of the countries of Central Asia and the Pacific to be committed to eliminating hepatitis, by guaranteeing universal access and health insurance for the screening of hepatitis and hepatitis. the treatment of the entire population.

The Western Pacific region has the largest number of people living with chronic hepatitis in the six regions of WHO. By the end of 2015, an estimated 14 million people are living with chronic hepatitis C of 115 million with chronic hepatitis B infection. One day, 1,200 people in the region are dying because they do not have access to effective treatment against hepatitis B.